Eric McFarland to Serve as NewHydrogen Chief Technology Officer
NewHydrogen has appointed Dr. Eric McFarland as Chief Technology Officer to lead the development and commercialization of their ThermoLoop™ technology. ThermoLoop is a breakthrough innovation that produces green hydrogen using water and heat instead of electricity, potentially offering the world's cheapest hydrogen production method.
Dr. McFarland, who brings extensive experience in energy systems and reaction engineering, will collaborate with the scientific team at UC Santa Barbara led by Dr. Phil Christopher. His impressive background includes degrees from UC Berkeley and MIT, over 200 scientific publications, and more than 30 patents. He has founded several chemical technology companies and held executive positions, including roles at Symyx Technologies and Gas Reaction Technologies.
The company recently filed a joint U.S. patent application with UCSB for their novel hydrogen production process, marking a significant milestone in ThermoLoop's development. This appointment signals NewHydrogen's commitment to advancing their green hydrogen technology from laboratory scale to commercial deployment.
NewHydrogen ha nominato il dott. Eric McFarland come Chief Technology Officer per guidare lo sviluppo e la commercializzazione della loro tecnologia ThermoLoop™. ThermoLoop rappresenta un'innovazione rivoluzionaria che produce idrogeno verde utilizzando acqua e calore anziché elettricità, offrendo potenzialmente il metodo di produzione di idrogeno più economico al mondo.
Il dott. McFarland, che vanta una vasta esperienza nei sistemi energetici e nell'ingegneria delle reazioni, collaborerà con il team scientifico dell'UC Santa Barbara guidato dal dott. Phil Christopher. Il suo profilo è impressionante, con titoli accademici ottenuti presso UC Berkeley e MIT, oltre 200 pubblicazioni scientifiche e più di 30 brevetti. Ha fondato diverse aziende nel settore della tecnologia chimica e ricoperto ruoli dirigenziali, tra cui posizioni presso Symyx Technologies e Gas Reaction Technologies.
Recentemente, l'azienda ha depositato una domanda di brevetto congiunta negli Stati Uniti insieme a UCSB per il loro innovativo processo di produzione di idrogeno, segnando una tappa importante nello sviluppo di ThermoLoop. Questa nomina sottolinea l'impegno di NewHydrogen nel portare la loro tecnologia di idrogeno verde dalla fase di laboratorio alla commercializzazione.
NewHydrogen ha nombrado al Dr. Eric McFarland como Director de Tecnología para liderar el desarrollo y la comercialización de su tecnología ThermoLoop™. ThermoLoop es una innovación revolucionaria que produce hidrógeno verde usando agua y calor en lugar de electricidad, ofreciendo potencialmente el método de producción de hidrógeno más barato del mundo.
El Dr. McFarland, con amplia experiencia en sistemas energéticos e ingeniería de reacciones, colaborará con el equipo científico de la Universidad de California en Santa Bárbara dirigido por el Dr. Phil Christopher. Su impresionante trayectoria incluye títulos de UC Berkeley y MIT, más de 200 publicaciones científicas y más de 30 patentes. Ha fundado varias empresas de tecnología química y ocupado cargos ejecutivos, incluyendo roles en Symyx Technologies y Gas Reaction Technologies.
Recientemente, la empresa presentó una solicitud conjunta de patente en EE. UU. junto con UCSB para su novedoso proceso de producción de hidrógeno, marcando un hito importante en el desarrollo de ThermoLoop. Este nombramiento refleja el compromiso de NewHydrogen de avanzar su tecnología de hidrógeno verde desde la escala de laboratorio hasta su implementación comercial.
NewHydrogen는 ThermoLoop™ 기술의 개발 및 상용화를 이끌 최고기술책임자(CTO)로 에릭 맥팔랜드 박사를 임명했습니다. ThermoLoop는 전기 대신 물과 열을 사용해 친환경 수소를 생산하는 혁신적인 기술로, 세계에서 가장 저렴한 수소 생산 방법이 될 가능성을 지니고 있습니다.
에릭 맥팔랜드 박사는 에너지 시스템 및 반응 공학 분야에서 풍부한 경험을 갖고 있으며, 필 크리스토퍼 박사가 이끄는 UC 산타바버라 과학팀과 협력할 예정입니다. 그는 UC 버클리와 MIT에서 학위를 받았고, 200편 이상의 과학 논문과 30건 이상의 특허를 보유하고 있습니다. 또한 여러 화학 기술 기업을 창업했으며 Symyx Technologies와 Gas Reaction Technologies에서 임원직을 역임했습니다.
최근 회사는 UCSB와 공동으로 미국 특허 출원을 하여 혁신적인 수소 생산 공정을 보호했으며, 이는 ThermoLoop 개발에 중요한 이정표입니다. 이번 임명은 NewHydrogen이 실험실 단계를 넘어 친환경 수소 기술의 상용화를 본격 추진하겠다는 의지를 보여줍니다.
NewHydrogen a nommé le Dr Eric McFarland au poste de Chief Technology Officer pour diriger le développement et la commercialisation de leur technologie ThermoLoop™. ThermoLoop est une innovation révolutionnaire qui produit de l'hydrogène vert en utilisant de l'eau et de la chaleur au lieu de l'électricité, offrant potentiellement la méthode de production d'hydrogène la moins coûteuse au monde.
Le Dr McFarland, qui possède une vaste expérience dans les systèmes énergétiques et l'ingénierie des réactions, collaborera avec l'équipe scientifique de l'UC Santa Barbara dirigée par le Dr Phil Christopher. Son parcours impressionnant comprend des diplômes de l'UC Berkeley et du MIT, plus de 200 publications scientifiques et plus de 30 brevets. Il a fondé plusieurs entreprises de technologie chimique et occupé des postes de direction, notamment chez Symyx Technologies et Gas Reaction Technologies.
L'entreprise a récemment déposé une demande de brevet conjointe aux États-Unis avec l'UCSB pour leur nouveau procédé de production d'hydrogène, marquant une étape importante dans le développement de ThermoLoop. Cette nomination témoigne de l'engagement de NewHydrogen à faire passer leur technologie d'hydrogène vert du laboratoire à la commercialisation.
NewHydrogen hat Dr. Eric McFarland zum Chief Technology Officer ernannt, der die Entwicklung und Kommerzialisierung ihrer ThermoLoop™-Technologie leiten wird. ThermoLoop ist eine bahnbrechende Innovation, die grünen Wasserstoff durch die Nutzung von Wasser und Wärme anstelle von Strom produziert und damit möglicherweise die weltweit kostengünstigste Methode zur Wasserstofferzeugung darstellt.
Dr. McFarland bringt umfangreiche Erfahrung in Energiesystemen und Reaktionstechnik mit und wird mit dem wissenschaftlichen Team der UC Santa Barbara unter der Leitung von Dr. Phil Christopher zusammenarbeiten. Sein beeindruckender Werdegang umfasst Abschlüsse von der UC Berkeley und dem MIT, über 200 wissenschaftliche Veröffentlichungen und mehr als 30 Patente. Er hat mehrere Chemietechnologieunternehmen gegründet und leitende Positionen innegehabt, unter anderem bei Symyx Technologies und Gas Reaction Technologies.
Das Unternehmen hat kürzlich gemeinsam mit UCSB eine US-Patentanmeldung für ihren neuartigen Wasserstoffproduktionsprozess eingereicht, was einen bedeutenden Meilenstein in der Entwicklung von ThermoLoop darstellt. Diese Ernennung unterstreicht NewHydrogens Engagement, ihre grüne Wasserstofftechnologie vom Labormaßstab zur kommerziellen Anwendung zu bringen.
- Appointment of highly qualified CTO Dr. Eric McFarland with extensive industry experience and academic credentials
- ThermoLoop technology breakthrough uses water and heat instead of electricity for cheaper green hydrogen production
- Recent joint U.S. patent application filed with UCSB for novel hydrogen production process
- CTO brings track record of successful commercialization (e.g., Symyx Technologies IPO)
- Strong intellectual property portfolio (McFarland holds over 30 patents)
- Established research partnership with University of California, Santa Barbara
- Technology still in early development phase, not yet commercially proven
- Commercial deployment timeline and costs remain undefined
- Operating on OTC markets (OTCQB) rather than major exchanges
Veteran energy expert to lead technical development and commercialization of the Company’s green hydrogen technology
SANTA CLARITA, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCQB:NEWH), the developer of ThermoLoop™, a breakthrough technology that uses water and heat rather than electricity to produce the world’s cheapest green hydrogen, today announced the appointment of Dr. Eric McFarland as Chief Technology Officer.
As CTO, Dr. McFarland will evolve the company’s technology strategy and help accelerate ThermoLoop’s advancement from the laboratory and pilot scale to the commercial marketplace. McFarland will also continue to work with the scientific team at the University of California, Santa Barbara (UCSB), led by Dr. Phil Christopher.
“Dr. McFarland brings deep technical insight and decades of experience in energy systems and reaction engineering,” said Steve Hill, CEO of NewHydrogen. “He’s played a key role in shaping our technology development through our UCSB partnership. As CTO, he will continue to focus on ThermoLoop technology development and proof of concept. Dr. McFarland is also uniquely qualified to guide us through the commercial demonstration process.”
“I’m excited to expand my role with NewHydrogen at this pivotal time,” said Dr. McFarland. “We’ve already demonstrated the scientific viability of this technology, and I look forward to working closely with the team to optimize performance, reduce costs, and move toward commercial deployment.”
Eric McFarland studied Nuclear Engineering and received B.S. and M.S. degrees from U.C. Berkeley, and his Ph.D. from the Massachusetts Institute of Technology. He joined the Nuclear Engineering faculty at MIT where his research moved from nuclear reaction fundamentals to use of nuclear phenomena for non-destructive materials and chemical analysis. In 1991 McFarland moved to the University of California, Santa Barbara, where he is a Professor of Chemical Engineering. McFarland’s academic research in energy conversion technology and reaction engineering has been both fundamental and applied. He has published over 200 scientific papers and is the inventor on over 30 patents.
McFarland has always worked closely with industry and has been a founder or co-founder of a number of chemical technology companies and has served in several executive and Board positions. Together with other University faculty, he was one of the founding directors of Symyx Technologies a chemical technology start-up that went on to have a successful public offering. McFarland served as CEO and President of Gas Reaction Technologies Inc. (GRT) that had major R&D programs with several global oil and gas companies. McFarland was awarded the Dow Chemical Chair of Chemical Engineering at the University of Queensland, Australia and spent two-years as the founding Director of the Dow Centre for Sustainable Engineering Innovation. He was a founder and served as Chief Technology Officer of CZero a company developing technology to use fossil resources for hydrogen production without carbon dioxide emissions. McFarland also studied medicine and earned an M.D. from Harvard Medical School and did post-graduate training in general surgery. He practiced part-time in Emergency Medicine and worked as a volunteer physician for several relief agencies.
NewHydrogen recently filed a joint U.S. patent application with UCSB for its novel hydrogen production process, marking a significant milestone in the development of its ThermoLoop technology.
To learn more about ThermoLoop™ and NewHydrogen’s mission to deliver the world’s cheapest green hydrogen, please visit https://newhydrogen.com.
About NewHydrogen, Inc.
NewHydrogen is developing ThermoLoop™ – a breakthrough technology that uses water and heat rather than electricity to produce the world’s lowest cost green hydrogen. Hydrogen is the cleanest and most abundant element in the universe, and we can’t live without it. Hydrogen is the key ingredient in making fertilizers needed to grow food for the world. It is also used for transportation, refining oil and making steel, glass, pharmaceuticals and more. Nearly all the hydrogen today is made from hydrocarbons like coal, oil, and natural gas, which are dirty and limited resources. Water, on the other hand, is an infinite and renewable worldwide resource.
Currently, the most common method of making green hydrogen is to split water into oxygen and hydrogen with an electrolyzer using green electricity produced from solar or wind. However, green electricity is and always will be very expensive. It currently accounts for
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, the impact on the national and local economies resulting from terrorist actions, the impact of public health epidemics on the global economy and other factors detailed in reports filed by the Company with the United States Securities and Exchange Commission.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Investor Relations Contact:
NewHydrogen, Inc.
ir@newhydrogen.com
FAQ
What is NewHydrogen's (NEWH) ThermoLoop technology and how does it produce green hydrogen?
Who is Dr. Eric McFarland and what is his role at NewHydrogen (NEWH)?
How is NewHydrogen (NEWH) collaborating with UC Santa Barbara on hydrogen technology?
What are Dr. Eric McFarland's qualifications for leading NewHydrogen's (NEWH) technology development?
What recent milestones has NewHydrogen (NEWH) achieved with its hydrogen technology?
